Clinical Trials Sponsored by Cinfa Biotech

Total 1820 results

Sinovac Life Sciences Co., Ltd.

Completed

Safety and Immunogenicity Study of Booster Vaccination in Different Doses of COVID-19 Vaccine (Vero Cell),Inactivated for Prevention of COVID-19

COVID-19

China
He Huang
Nanjing Bioheng Biotech Co., Ltd.

Unknown

Peripheral Blood Mononuclear Cell Collection Protocol for UCART Cell Tumor Immunotherapy Study

Peripheral Blood Mononuclear Cell

China
Shanghai Public Health Clinical Center
R&D Kanglin Biotech

Unknown

An Efficacy and Safety Study of shRNA-modified CD34+ Cells in HIV-infected Patients.

HIV Infections | AIDS

China
US Oncology Research
Ortho Biotech, Inc.; Tibotec Pharmaceutical Limited

Completed

Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer

Metastatic Breast Cancer

United States
Xiamen Amoytop Biotech Co., Ltd.
Peking University First Hospital

Completed

Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B

Chronic Hepatitis B

China
Dallas VA Medical Center
Centocor Ortho Biotech Services, L.L.C.

Completed

Exacerbating Factors in Inflammatory Bowel Disease

Crohn's Disease | Ulcerative Colitis

United States
Johnson & Johnson Pharmaceutical Research & Development...
Ortho Biotech, Inc.

Terminated

A Safety and Dose-finding Study of JNJ-38877605 in Patients With Advanced or Refractory Solid Tumors.

Neoplasms
Clinica Universidad de Navarra, Universidad de...
Fina Biotech

Terminated

Treatment With Autologous Skeletal Myoblasts

Old Myocardial Infarction

Spain
University of Calgary
Ortho Biotech, Inc.; Calgary Health Region

Completed

The Erythropoietin NeuroProtective Effect: Assessment in CABG Surgery (TENPEAKS)

Brain Injury | Cardiac Surgery

Canada
IRCCS San Raffaele
University Of Perugia; Lorenz Biotech S.p.A.

Completed

Electromagnetic Stimulation (FREMS) in Patients With Painful Diabetic Neuropathy

Painful Diabetic Neuropathy

Italy
Cipla BioTec Pvt. Ltd.
Quintiles, Inc.

Unknown

PK Bioequivalence Single-dose Safety Tolerability Study in Healthy Male Volunteers to Compare CBT124 & Avastin(EU&US) (CBT124NHV001)

Healthy

New Zealand
Intech Biopharm Ltd.

Recruiting

Pharmacodynamic Equivalence of the Test and Reference Metered Dose Inhalers (MDIs) Containing Albuterol Sulfate in Adult Patients With Stable Mild Asthma

Mild Asthma

Taiwan, India
Intech Biopharm Ltd.

Completed

Bioequivalence Study of Synflutide HFA Inhaler and Seretide Evohaler in Healthy Volunteers Without Charcoal Block

Asthma | Chronic Obstructive Pulmonary Disease (COPD)

Taiwan
Intech Biopharm Ltd.

Completed

Multiple-dose Pharmacokinetics Study of "SYN006 HFA MDI" Administered Orally to Healthy Volunteers

Asthma

Taiwan
Intech Biopharm Ltd.

Completed

Bioequivalence Between Albuterol Sulfate Inhalation Aerosol 108mcg Per Actuation and Proair HFA (Albuterol Sulfate) Inhalation Aerosol 90mcg Per Actuation in Healthy Volunteers Under Fasting Conditions

Healthy

Taiwan
Intech Biopharm Ltd.

Completed

A Bioequivalence Pivotal Study of SYN010 HFA Inhaler and Symbicort® 160/4.5 in Healthy Volunteers With Charcoal Block

Asthma | Chronic Obstructive Pulmonary Disease (COPD)
University Hospital, Lille
Biotest

Recruiting

Efficacy and Safety of Cytotect®CP, Hyperimmune Anti-CMV IVIg as CMV Prophylaxis in Patients Developing Acute Grade II-IV GVHD After Allogeneic Hematopoietic Cell Transplantation. (CMV-GVHD)

Cytomegalovirus Infections

France
RWTH Aachen University
Biotest

Recruiting

Prospective, Randomized Trial of Personalized Medicine With Pentaglobin® After Surgical Infectious Source Control in Patients With Peritonitis (PEPPER Trial). (PEPPER)

Sepsis | Septic Shock | Peritonitis

Austria, Germany
Vabiotech
Vietstar Biomedical Research

Completed

The Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine Institute in Children of Viet Nam Healthy From 6 to 12 Weeks of Age in a 3-dose Regimen, the Interval Between Doses is 4 Weeks

Hepatitis B | Pertussis | Tetanus | Diphtheria | Haemophilus Influenzae Type B

Vietnam
Intech Biopharm Ltd.

Completed

Bioequivalence Between Albuterol Sulfate Inhalation Aerosol 108 mcg Per Actuation and Proair HFA (Albuterol Sulfate) Inhalation Aerosol 90 mcg Per Actuation in Healthy Volunteers Under Fasting Conditions

Healthy

Taiwan
Intech Biopharm Ltd.

Completed

A Bioequivalence Pivotal Study of SYN010 HFA Inhaler and Symbicort® 160/4.5 in Healthy Volunteers Without Charcoal Block

Asthma | COPD

Taiwan
Intech Biopharm Ltd.

Completed

Bioequivalence Study of Synflutide HFA Inhaler and Seretide Evohaler in Healthy Volunteers With Charcoal Block

Asthma | Chronic Obstructive Pulmonary Disease (COPD)

Taiwan
Intech Biopharm Ltd.

Completed

Bioavailability Study of SYN006, Pulmicort pMDI and Meptin Air in Healthy Adult.

Asthma | Chronic Obstructive Pulmonary Disease (COPD)

Taiwan
Intech Biopharm Ltd.

Completed

Efficacy Study of SYN006 HFA MDI in Asthma Patients

Asthma

Taiwan
University Hospital, Bordeaux
Biotest

Recruiting

Association of T Gamma Delta-CD16+ Cells and Anti-CMV Immunoglobulins in the Prevention of CMV Infection (SYNTAGME)

Kidney Transplantation | CMV Infection

France
Mitotech, SA
ORA, Inc.

Completed

Vehicle-Controlled Study of SkQ1 as Treatment for Dry-eye Syndrome (VISTA-2)

Dry Eye Syndrome

United States
Mitotech, SA
ORA, Inc.

Completed

A Clinical Study to Assess the Safety and Efficacy of an Ophthalmic Solution (SkQ1) in the Treatment of Dry Eye Syndrome (DES)

Keratoconjunctivitis Sicca

United States
Hannover Medical School
Biotest

Recruiting

Treatment of Patients With Chronic Hepatitis B With Hepatitis B Immunoglobulins (HBIG)

Chronic Hepatitis B

Germany
Vabiotech
Vietstar Biomedical Research

Not yet recruiting

Assess the Safety and Immunogenicity of PNEUMOSIL® Vaccine in Healthy Vietnamese Children, 6 Weeks to 24 Months of Age (PNEUMOSIL)

Vaccine Preventable Disease | Streptococcus Pneumonia
Biotest
PRA Health Sciences

Completed

Adjusted Fibrinogen Replacement Strategy (AdFIrst)

Bleeding Disorder | Hypofibrinogenemia; Acquired

Belgium, Czechia, Germany, Poland, Spain, Switzerland, United Kingdom
Mitotech, SA
ORA, Inc.

Completed

Study of SkQ1 as Treatment for Dry-eye Syndrome (VISTA-1)

Dry Eye Syndrome

United States
Memorial Sloan Kettering Cancer Center
BioNTech SE

Active, not recruiting

Study of a New Technique for Imaging Pancreatic Cancer

Pancreatic Cancer | Tumors That Express CA19-9

United States
David Garcia Cinca
Fundacion Clinic per a la Recerca Biomédica; Miquel Ferrer - Investigator Coordinator

Unknown

Adequate Duration of Antibiotic Treatment in Community-acquired Pneumonia With High Risk Class and Adequate Initial Clinical Response (2017-001406-15)

Community-acquired Pneumonia

Spain
Genmab
Merck Sharp & Dohme LLC; BioNTech SE

Recruiting

Safety and Efficacy Study of GEN1046 as a Single Agent or in Combination With Pembrolizumab for Treatment of Recurrent (Non-small Cell) Lung Cancer

Non Small Cell Lung Cancer Metastatic

United States, Spain, Netherlands, Italy, France, United Kingdom, Poland, Germany, Portugal
WomenX Biotech Limited
Hong Kong Science and Technology Parks Corporation

Recruiting

Non-invasive Biomarker Discovery for Pre-cervical or/and Cervical Cancer-HPV DNA and Other Biomarkers in Urine

Cervical Cancer

Hong Kong
Sinovac Research and Development Co., Ltd.

Recruiting

A Phase 1b Clinical Trial of 13-valent Pneumococcal Polysaccharide Conjugate Vaccine

Pneumococcal Infectious Disease

China
Chongqing Precision Biotech Co., Ltd
Peking University Cancer Hospital & Institute

Recruiting

Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/Refractory B Cell Lymphoma

B Cell Lymphoma | Non Hodgkin Lymphoma

China
Peking Union Medical College Hospital
Shanghai Reunion Biotech Co.,Ltd.

Recruiting

The Long-term Benefit of Hydrogel Spacer in Reducing Rectal Radiation Dose in Cervical Cancer Radiation Therapy.

Uterine Cervical Neoplasms

China
Institute of Hematology & Blood Diseases Hospital
R&D Kanglin Biotech

Recruiting

Evaluation the Safety and Efficacy of KL003 Cell Injection in the Treatment of Transfusion-dependent β-thalassemia.

Transfusion-dependent Beta-Thalassemia

China
Biotech Pharmaceutical Co., Ltd.
Fudan University; NanJing PLA 81 Hospital

Completed

A Study of Nimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreatic Cancer

Pancreatic Cancer

China
Sinovac Research and Development Co., Ltd.

Completed

Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of COVID-19

COVID-19

China
Sinovac Research and Development Co., Ltd.

Completed

Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Adults

COVID-19

China
Sinovac Research and Development Co., Ltd.

Active, not recruiting

Effectiveness of Inactivated COVID-19 Vaccine of the First Booster Dose

COVID-19

Brazil
Sinovac Research and Development Co., Ltd.

Completed

Effectiveness of COVID-19 Vaccine for Prevention of COVID-19 in the Dominican Republic

COVID-19

Dominican Republic
Sinovac Research and Development Co., Ltd.

Suspended

Immunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated (CoronaVac®) Vaccine in Healthy Adults in Turkey

COVID-19

Turkey
National Institute of Allergy and Infectious Diseases...
Facet Biotech

Completed

Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS

HIV Infections | Cytomegalovirus Retinitis

United States
Sinovac Research and Development Co., Ltd.

Completed

Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants

Mumps

China
Sinovac Research and Development Co., Ltd.

Completed

Study on Combined Vaccination With SARS-CoV-2 Inactivated Vaccine and Quadrivalent Influenza Vaccine

COVID-19 | Influenza

China
Bharat Biotech International Limited
Georgia Institute for Clinical Research, LLC

Completed

To Determine the Safety and Efficacy of Liquid ROTAVAC 5C Vaccine Against Childhood Diarrhea Caused by Rotavirus (ROTAVAC5C)

Rotavirus Gastroenteritis
First Affiliated Hospital Xi'an Jiaotong University
Nanjing Legend Biotech Co.

Terminated

A Phase 1 Study of LCAR-C182A Cells in the Treatment of Advanced Gastric Cancer and Pancreatic Ductal Adenocarcinoma

Gastric Cancer | Pancreatic Ductal Adenocarcinoma

China

3

Subscribe